Home / Sweden / Ascelia Pharma AB
Ascelia Pharma AB
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
18 disclosures on record
Evolution of the disclosed total
0%0.2%0.4%0.6%0.8%
Oct 2025Jan 2026Apr 2026Jul 2026
March 18, 2021 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 23, 2026 | Citadel Securities (Europe) Limited | 0.73% | still open |
| July 22, 2026 | Citadel Securities (Europe) Limited | 0.68% | still open |
| July 16, 2026 | Citadel Securities (Europe) Limited | 0.73% | still open |
| July 15, 2026 | Citadel Securities (Europe) Limited | 0.57% | still open |
| July 13, 2026 | Citadel Securities (Europe) Limited | 0.79% | still open |
| July 10, 2026 | Citadel Securities (Europe) Limited | 0.68% | still open |
| July 6, 2026 | Citadel Securities (Europe) Limited | 0.79% | still open |
| September 18, 2024 | Guevoura Fund | 0.80% | still open |
| September 13, 2024 | Guevoura Fund | 0.78% | still open |
| September 11, 2024 | Guevoura Fund | 0.60% | still open |
| September 10, 2024 | Guevoura Fund | 1.36% | still open |
| September 9, 2024 | Guevoura Fund | 0.92% | still open |
| August 29, 2024 | Quartys Limited | 0.51% | still open |
| March 23, 2021 | Catella Fondförvaltning AB | 0.62% | March 23, 2021 |
| March 23, 2021 | Celina Fondförvaltning AB | 0.62% | still open |
| March 22, 2021 | Catella Fondförvaltning AB | 0.72% | still open |
| March 22, 2021 | Celina Fondförvaltning AB | 0.72% | still open |
| March 18, 2021 | Celina Fondförvaltning AB | 0.87% | still open |
Other companies sold short in Sweden
- Samhällsbyggnadsbolaget i Norden AB 12.26% of the capital sold short
- Elekta AB (publ) 9.63% of the capital sold short
- JM AB 7.01% of the capital sold short
- Hemnet Group AB (publ) 6.08% of the capital sold short
- Embracer Group AB 5.75% of the capital sold short
- Bonesupport Holding AB 5.67% of the capital sold short
- Truecaller AB 5.43% of the capital sold short
- Xvivo Perfusion Aktiebolag 4.91% of the capital sold short
- Tobii AB 4.34% of the capital sold short
- RaySearch Laboratories AB (publ) 4.16% of the capital sold short
- Dynavox Group AB 3.80% of the capital sold short
- Svenska Cellulosa Aktiebolaget SCA 3.77% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Ascelia Pharma AB, source Finansinspektionen, data as at July 23, 2026, https://www.quivad.com/action/ascelia-pharma-ab